The National Marrow Donor Program® (NMDP)/Be The Match® is the leading global partner working to save lives through cellular therapy. MINNEAPOLIS, May 24, 2023 (GLOBE NEWSWIRE) -- Be The Match ...

MINNEAPOLIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- NMDP BioTherapies℠, formerly Be The Match BioTherapies, announced that Tom Hochuli will serve as president, leading the organization into its promising ...

MINNEAPOLIS--(BUSINESS WIRE)--NMDP BioTherapies℠, formerly Be The Match BioTherapies, a leader in cell and gene therapy development support, unveiled substantial upgrades to its cellular starting ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Biotherapies – a key focus at the UPMC Vision Institute ...

Nottingham-based optics tissue-therapy company NuVision Biotherapies has strengthened its board with a key appointment.

The emergence of new biotherapeutics is both the driver and result of innovative drug development technologies. The emergence of new biotherapeutics has prompted the advancement of innovative ...

MINNEAPOLIS--(BUSINESS WIRE)--Be The Match BioTherapies ®, an organization offering solutions for companies developing and commercializing cell and gene therapies, today announced a collaboration with ...

Study in conjunction with investigators from Labor Quade and the Johns Hopkins School of Medicine analyzed the longer-term stability of IDM analytes in uncentrifuged peripheral blood samples to allow ...

Be The Match BioTherapies will provide streamlined supply chain services in support of Orchard’s commercial-stage gene therapy in Europe Through the expanded partnership, Be The Match BioTherapies ...

At Cambridge Biotherapies, we understand how deeply depression and anxiety can affect every part of your life. You may feel exhausted from trying treatments that haven’t brought the relief you need, ...

(MENAFN- GlobeNewsWire - Nasdaq) Tom Hochuli will lead the organization as it renews its commitment to advancing cell and gene therapy MINNEAPOLIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- NMDP ...